Literature DB >> 8705902

Triple-marker screening for Down syndrome.

G Viner.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8705902      PMCID: PMC1487987     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Prenatal screening for Down's syndrome with use of maternal serum markers.

Authors:  J E Haddow; G E Palomaki; G J Knight; J Williams; A Pulkkinen; J A Canick; D N Saller; G B Bowers
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

2.  A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.

Authors:  E Y Cheng; D A Luthy; A M Zebelman; M A Williams; R E Lieppman; D E Hickok
Journal:  Obstet Gynecol       Date:  1993-01       Impact factor: 7.661

3.  Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.

Authors:  N J Wald; A Kennard; J W Densem; H S Cuckle; T Chard; L Butler
Journal:  BMJ       Date:  1992-08-15

4.  Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.

Authors:  O P Phillips; S Elias; L P Shulman; R N Andersen; C D Morgan; J L Simpson
Journal:  Obstet Gynecol       Date:  1992-09       Impact factor: 7.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.